Pneumococcal conjugate second or third-dose vaccines (PCVc) in South Africa
South Africa: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 65.0% in 2025. β² Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in South Africa, 2008β2025
Source: World Health Organization, Global Health Observatory.
Analysis
South Africa recorded 65.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
That represents a change of down 20.7% on the previous year and down 23.5% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in South Africa peaked at 89.0% in 2022 and was at its lowest, 0.0%, in 2008.
South Africa ranks 138th of 192 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.0% | 0.0% | 10.0% | 2 |
| 2010s | 77.2% | 58.0% | 86.0% | 10 |
| 2020s | 81.7% | 65.0% | 89.0% | 6 |
Countries ranked near South Africa
More health data for South Africa
- Un projection of annual infant deaths, annual growth rate -2.2 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1386 % change on previous year (2090)
- Heat deaths vs projected death rates 1,152 (2090)
- Un projection of annual infant deaths 3,333 (2100)
- Population, male, annual growth rate 1.13 % change on previous year (2025)
- Population, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population, male, per capita 0.4866 units per person (2025)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 541,701 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in South Africa?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in South Africa was 65.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in South Africa?
- The highest recorded value was 89.0% in 2022.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in South Africa?
- The lowest recorded value was 0.0% in 2008.
- How does South Africa rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- South Africa ranks 138th out of 192 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in South Africa?
- Over the last ten years it is down 23.5%. The long-run trend across the full record is rising.
- Where does this South Africa data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).